高级检索
当前位置: 首页 > 详情页

Effects of HuoxueJiangtang decoction alone or in combination with metformin on renal function and renal cortical mRNA expression in diabetic nephropathy rats.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Endocrinology, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, China [2]Institute of National Master ofTCM, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China
出处:
ISSN:

关键词: Blood glucose biochemical indicator pathological change kidney

摘要:
HuoxueJiangtang decoction (ZY) is a traditional Chinese medicine for the treatment of diabetes. The protective effect of ZY on renal injury in diabetic nephropathy rats was investigated in this study. Fifty 4-week-old SPF Wistar male rats were selected to construct diabetic nephropathy model rats (DN) group by continuous high-fat feeding for 4 weeks, followed by a tail vein injection of 30 mg/kg streptozotocin for 1 week. The experimental rats were divided into six groups of 10 rats: normal (control), DN, DN + ZY, DN + metformin, DN + metformin + ZY, and DN + metformin + captopril (positive control) groups. Among the groups, 6.25 g/kg ZY, 250 mg/kg metformin, and 17.5 mg/kg captopril were given to the rats by gavage once a day for 16 weeks. Blood glucose, dietary behaviour, biochemical indicators, and gene expression changes were measured in each group. Metformin + ZY treatment significantly lowered blood glucose, water intake, urine total protein, urine albumin, urine volume, serum triglyceride, and serum cholesterol levels in the DN group. The pathological changes of kidney tissue showed that the DN + metformin + ZY group had a protective effect on kidney tissue damage. And ZY and metformin + ZY treatments repaired the expression of genes in the DN group. The ZY and metformin combined treatment showed a clear therapeutic effect on kidney damage in DN. This study provides a potential mechanism for the treatment of diabetic nephropathy with ZY combined with metformin.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 4 区 医学
小类 | 3 区 医学实验技术 3 区 植物科学 4 区 药学
最新[2025]版:
大类 | 3 区 医学
小类 | 2 区 医学实验技术 2 区 药学 2 区 植物科学
JCR分区:
出版当年[2018]版:
Q2 MEDICAL LABORATORY TECHNOLOGY Q2 PLANT SCIENCES Q3 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q1 MEDICAL LABORATORY TECHNOLOGY Q1 PHARMACOLOGY & PHARMACY Q1 PLANT SCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Department of Endocrinology, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, China
共同第一作者:
通讯作者:
通讯机构: [1]Department of Endocrinology, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, China [*1]Department of Endocrinology, Shenzhen Traditional Chinese Medicine Hospital, 1# Fuhua Road, Shenzhen, Futian District, 518033, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号